VITURA overview

Regulatory News: Having obtained all the necessary administrative authorizations, Vitura (Paris:VTR) is pressing ahead with its plans to bring the Passy Kennedy and Office Kennedy properties together within a single 34,000 sq.m complex, to be known as the "Kennedy Campus". One of the aims of this flagship operation is to refocus the Company’s portfolio on the wider Paris CBD. Discussions on financing arrangements (both debt and capital) for the project are currently underway with major...

Regulatory News: Vitura (Paris:VTR): A unique user experience Among Vitura’s buildings in use, Europlaza in La Défense and Arcs de Seine in Boulogne Billancourt have been highly attractive during the first semester of 2023, with 11,000 sq.m let, i.e. 8% of the surface area, and of one of the few leases transaction exceeding 5,000 sq.m. Rents reach €500/sq.m/year in Boulogne and €480/sq.m/year in La Défense. Vitura’s properties provide a standout user experience, particularly notable...

Regulatory News: Vitura (Paris:VTR) announces it has signed a lease of 5,820 sq.m of space in building C at Arcs de Seine in Boulogne Billancourt to a leading telecommunications operator. Two other tenants – a television production company and a radio station – have also moved into building C, taking up a total of 4,000 sq.m. The 10,000 sq.m building was entirely reimagined by G+ Architectes, with a focus on new user practices. The revamped property adopts features of hotel design in common...

Regulatory News: Vitura (Paris:VTR): Key information €12.7 million in IFRS rental income in first-quarter 2023 100% of rents and charges collected 3,000 sq.m signed and more than 5,000 sq.m in exclusivity Continuation of repositioning programs Unaudited figures. Strong sales momentum around sustainable urban campuses In the first quarter of 2023, operating momentum continued with 3,000 sq.m signed and the entry in exclusivity of more than 5,000 sq.m. The portfolio in operation occupancy rate...

CORTEXA TO BE THE LEADING SUPPLIER OF MDMA AND PSILOCYBIN IN AUSTRALIA VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ”)(CSE: MDMA) is pleased to announce the establishment of a 50:50 joint venture, "Cortexa", with Australian-based Vitura Health Limited (ASX: VIT) (“ Vitura ”). Following the execution of a letter of intent between Vitura and PharmAla in late February, the parties have executed definitive agreements (the "...

Regulatory News: VITURA (Paris:VTR): The Company announces the publication of its Universal registration document including the annual financial report for 2021. The Universal registration document including the annual financial report for fiscal year 2022 was submitted to the Autorité des marchés financiers (AMF) on 4 April 2023. This document is available on the websites of: VITURA ( www.vitura.fr ), Investors section AMF ( www.amf-france.org ). Copies of the Universal registration document...

Regulatory News: Vitura (Paris:VTR): “ Despite the different geopolitical, macroeconomic, climate and financial challenges faced in 2022, it was a strong year for Vitura. Portfolio activity was brisk, demonstrating the attractiveness of our properties on the market. In our constant pursuit to create value for our shareholders over the long term and provide our tenants with premium workplaces, we have continued to improve and enhance our portfolio, to combine the best levels of service with the...

Regulatory News: Vitura (Paris:VTR): Strong operating performance In the first nine months of 2022, Vitura recorded IFRS rental income of €40.2 million, compared with €42.7 million in the prior-year period. The decrease is mainly due to the departure of Crédit Foncier de France from half of the office space at Rives de Bercy in July 2021, as well as the departure of Canal+ from the Arcs de Seine building in October 2021. The acquisition of the Office Kennedy building, which generated rental...